It has been discovered that higher levels of Integrin alpha 6 (ITGA6) are expressed in the highly invasive pancreatic cancer cells than in less invasive cells, resulting in a poor prognosis in pancreatic patients via TCGA (Wu Y. et al., 2019). The gene discussed is ITGA6; the disease is familial pancreatic carcinoma.